Laura Archuleta, MD | |
2500 Sunset Drive Nw, Mandan, ND 58554 | |
(701) 667-4600 | |
(701) 530-3780 |
Full Name | Laura Archuleta |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 23 Years |
Location | 2500 Sunset Drive Nw, Mandan, North Dakota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245284314 | NPI | - | NPPES |
1454485 | Medicaid | ND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QH0002X | Family Medicine - Hospice And Palliative Medicine | 9721 (North Dakota) | Secondary |
207Q00000X | Family Medicine | 9721 (North Dakota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Chi Health At Home | Bismarck, ND | Home health agency |
Chi Health At Home | Bismarck, ND | Hospice |
Chi Health At Home | Dickinson, ND | Hospice |
Chi Health At Home | Breckenridge, MN | Hospice |
Chi Health At Home | Valley city, ND | Hospice |
Chi Health At Home | Williston, ND | Hospice |
Chi St Alexius Health | Bismarck, ND | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Alexius Medical Center | 8426960865 | 205 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.
A molecule consisting of two "cages" of metallic atoms bound to carbon has shown great promise in preliminary tests of becoming a new weapon in the anti-HIV arsenal, researchers at UT Southwestern Medical Center report.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
› Verified 7 days ago
Entity Name | St Alexius Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205868429 PECOS PAC ID: 8426960865 Enrollment ID: O20031104000146 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.
A molecule consisting of two "cages" of metallic atoms bound to carbon has shown great promise in preliminary tests of becoming a new weapon in the anti-HIV arsenal, researchers at UT Southwestern Medical Center report.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Laura Archuleta, MD Po Box 997, Bismarck, ND 58502-0997 Ph: (701) 667-4600 | Laura Archuleta, MD 2500 Sunset Drive Nw, Mandan, ND 58554 Ph: (701) 667-4600 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.
A molecule consisting of two "cages" of metallic atoms bound to carbon has shown great promise in preliminary tests of becoming a new weapon in the anti-HIV arsenal, researchers at UT Southwestern Medical Center report.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
› Verified 7 days ago
Meghan Hendrickson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 Mandan Ave, Mandan, ND 58554 Phone: 701-323-6000 | |
Boyd F Addy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2008 Twin City Dr, Mandan, ND 58554 Phone: 701-667-1000 Fax: 701-667-0707 | |
Dale A Klein, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 Fax: 701-323-5709 | |
Andrew Dockter, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 | |
Sadaf Yousuf, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 Fax: 701-667-5095 | |
Gretchen G Belzer-curl, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 Fax: 701-667-5095 |